Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing

BACKGROUND: Chemoresistance is one of the leading causes that severely limits the success of osteosarcoma treatment. Evaluating chemoresistance before chemotherapy poses a new challenge for researchers. We established an effective chemoresistance risk scoring model for prechemotherapy osteosarcoma u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ziliang, Li, Wenpeng, Zhang, Di, Zhang, Chi, Jiang, Xu, Guo, Rui, Wang, Zheyu, Yang, Canchun, Yan, Haolin, Zhang, Zhilei, Wang, Qiwei, Huang, Renyuan, Zhao, Qiancheng, Li, Bo, Hu, Xumin, Gao, Liangbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159767/
https://www.ncbi.nlm.nih.gov/pubmed/35664733
http://dx.doi.org/10.3389/fonc.2022.893282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159767/
https://www.ncbi.nlm.nih.gov/pubmed/35664733
http://dx.doi.org/10.3389/fonc.2022.893282

Ejemplares similares